Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes [4]

British Journal of Haematology

Volumn 123, Issue 5, 2003, Pages 958-

  Garypidou, Vasilia ^a   Verrou, Evgenia ^a   Vakalopoulou, Sofia ^a   Perifanis, Vasilios ^a   Tziomalos, Konstantinos ^a   Venizelos, Ioannis ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Ippokration Hospital Thessaloniki   (Greece)

Author keywords

Myelodysplastic syndromes; Recombinant erythropoietin

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LETTER; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME;

AGED; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TREATMENT OUTCOME;

EID: 0348110519     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04697.x     Document Type: Letter

References (4)

1. Mirtsching, B., Charu, V., Vadhan-Raj, S., Colowick, A.B., Rossi, G., Tomita, D. & McGuire, W.P. (2002) Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis. Oncology, 16, 31-36.
2. Musto, P., Falcone, A., Sanpaolo, G., Bodenizza, C., La Sala, A., Perla, G. & Carella, A.M. (2003) Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes. British Journal of Haematology, 122, 269-271.
3. Terpos, E., Mougiou, A., Kouraklis, A., Chatzivassili, A., Michalis, E., Giannakoulas, N., Manioudaki, E., Lazaridou, A., Bakaloudi, V., Protopappa, M., Liapi, D., Grouzi, E., Parharidou, A., Symeonidis, A., Kokkini, G., Laoutaris, P., Vaipoulos, G., Anagnostopoulos, N.I., Christakis, J., Meletis, J., Bourantas, K.L., Zoumbos, N.C., Yataganas, X. & Viniou, N.A. (2002) Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients. British Journal of Haematology, 118, 174-180.
4. Weiss, L.G., Clyne, N., Divino Fihlho, J., Frisenette-Fich, C., Kurkus, J. & Svensson, B. (2000) The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin beta: results from a randomized controlled multicentre trial. Swedish Study Group. Nephrology Dialysis and Transplantation, 15, 2014-2019.